Dianthus Therapeutics Inc. (DNTH) — Strategic Asset Allocation Index
Dianthus Therapeutics Inc. (DNTH) has a Strategic Asset Allocation Index of 25.9% as of June 2026. Strategic assets (PP&E of $- plus long-term investments of $303.63 Million) total $303.63 Million, measured against net assets of $1.17 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Dianthus Therapeutics Inc. (DNTH) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Dianthus Therapeutics Inc. Strategic Asset Allocation Index (2021–2025)
This chart shows how Dianthus Therapeutics Inc.'s Strategic Asset Allocation Index has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the index stands at 25.9%, representing strategic assets of $303.63 Million against net assets of $1.17 Billion USD. For live market cap and overall valuation, see Dianthus Therapeutics Inc. market cap and net worth.
Annual Strategic Asset Allocation Index for Dianthus Therapeutics Inc. (2021–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Dianthus Therapeutics Inc. from 2021 to 2025, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Dianthus Therapeutics Inc. shareholders equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 22.3% | $110.14 Million | $- | $110.14 Million | $493.40 Million | ▼ -0.9 pp |
| 2024 | 23.2% | $81.73 Million | $- | $81.73 Million | $352.48 Million | ▲ +23.2 pp |
| 2023 | 0.0% | $0.00 | $- | $0.00 | $168.87 Million | ▼ -1.3 pp |
| 2022 | 1.3% | $956.00K | $956.00K | $- | $73.66 Million | ▲ +1.3 pp |
| 2021 | 0.0% | $33.00K | $33.00K | $- | $172.67 Million | — |